Generic Name:
calaspargase pegol
Project Status:
Pending
Therapeutic Area:
Acute lymphoblastic leukemia (ALL)
Manufacturer:
Servier Canada Inc.
Call for patient/clinician input open:
Brand Name:
TBC
Project Line:
Reimbursement Review
Project Number:
PC0321-000
Call for patient/clinician input closed:
Tumour Type:
Leukemia
Details
Manufacturer Requested Reimbursement Criteria1:
As a component of a multi-agent chemotherapeutic (MAC) regimen for the treatment of patients with acute lymphoblastic leukemia (ALL).
Submission Type:
Initial
Fee Schedule:
Pending
Indications:
As a component of a multi-agent chemotherapeutic (MAC) regimen for the treatment of patients with acute lymphoblastic leukemia (ALL).
Anticipated Date:
- The requested reimbursement criteria are provided by the applicant and do not necessarily reflect the views of CADTH. Reimbursement criteria from CADTH will be documented in the final recommendation, if applicable.